tiprankstipranks
Carisma Therapeutics (CARM)
NASDAQ:CARM
US Market
Holding CARM?
Track your performance easily

Carisma Therapeutics (CARM) Technical Analysis

1,561 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Carisma Therapeutics’s (CARM) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Carisma Therapeutics is a Sell.
Carisma Therapeutics’s (CARM) 20-Day exponential moving average is 0.49, while Carisma Therapeutics’s (CARM) share price is $0.44, making it a Sell.
Carisma Therapeutics’s (CARM) 50-Day exponential moving average is 0.63, while Carisma Therapeutics’s (CARM) share price is $0.44, making it a Sell.

Carisma Therapeutics (CARM) Pivot Points

Jan 22, 2025, 10:55 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.39
0.40
0.43
0.45
0.48
0.49
0.52
Fibonacci
0.40
0.42
0.43
0.45
0.47
0.48
0.49
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Carisma Therapeutics (CARM) Moving Averages

Jan 22, 2025, 10:55 AM
Period
Simple
Exponential
MA5
0.45Sell
0.45Sell
MA10
0.48Sell
0.46Sell
MA20
0.45Sell
0.49Sell
MA50
0.67Sell
0.63Sell
MA100
0.83Sell
0.81Sell
MA200
1.09Sell
1.16Sell
Carisma Therapeutics’s (CARM) 10-Day exponential moving average is 0.46, while Carisma Therapeutics’s (CARM) share price is $0.44, making it a Sell.
Carisma Therapeutics’s (CARM) 100-Day exponential moving average is 0.81, while Carisma Therapeutics’s (CARM) share price is $0.44, making it a Sell.
Carisma Therapeutics’s (CARM) stock price is $0.44 and Carisma Therapeutics’s (CARM) 50-day simple moving average is 0.67, creating a Sell signal.
Carisma Therapeutics’s (CARM) stock price is $0.44 and Carisma Therapeutics’s (CARM) 100-day simple moving average is 0.83, creating a Sell signal.
Carisma Therapeutics’s (CARM) stock price is $0.44 and Carisma Therapeutics’s (CARM) 200-day simple moving average is 1.09, creating a Sell signal.

Carisma Therapeutics (CARM) Technical Indicators

Jan 22, 2025, 10:55 AM
Name
Value
Implied Action
RSI (14)
38.13
Neutral
STOCH (9,6)
16.30
Buy
STOCHRSI (14)
24.86
Neutral
MACD (12,26)
-0.05
Sell
ADX (14)
25.43
Neutral
Williams %R
-81.57
Buy
CCI (14)
-11.83
Neutral
ATR (14)
0.06
-
Ultimate Oscillator
39.59
Neutral
ROC
0.00
Buy
Carisma Therapeutics’s (CARM) Relative Strength Index (RSI) is 38.13, creating a Neutral signal.
Carisma Therapeutics’s (CARM) Trend Strength Indicator (ADX) is 25.43, creating a Neutral signal.
Carisma Therapeutics’s (CARM) Commodity Channel Index (CCI) is -11.83, creating a Neutral signal.

FAQ

Is CARM a Buy, Hold, or Sell?
Based on CARM’s technical indicators, CARM is a Strong Sell.
    What is CARM’s RSI (14)?
    CARM’s RSI (14) is 38.13, which suggests CARM is a Neutral.
      What is CARM’s MACD?
      CARM’s MACD is -0.05, which suggests CARM is a Sell.
        What is CARM’s 5-day moving average?
        CARM’s 5-day moving average is 0.45, which suggests CARM is a Sell.
          What is CARM’s 20-day moving average?
          CARM 20-day moving average is 0.45, which suggests CARM is a Sell.
            What is CARM’s 50-day moving average?
            CARM’s 50-day moving average is 0.67, which suggests CARM is a Sell.
              What is CARM’s 200-day moving average?
              CARM’s 200-day moving average is 1.09, which suggests CARM is a Sell.
                What is CARM’s Williams % R (14)?
                CARM’s Williams % R (14) is -81.57, which suggests CARM is a Buy.
                  What is CARM’s CCI (14)?
                  CARM’s CCI (14) is -11.83, which suggests CARM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis